CEO buying at CanniMed Therapeutics (T:CMED)

Brenton Harold Zettl, CEO and Director, acquired 14,500 Common Shares on a direct ownership basis at prices ranging from $7.988 to $8.000 between June 27th, 2017 and June 28th, 2017. This represents a $115,912 investment into the company's shares and an account share holdings change of 1.5%.

CanniMed Therapeutics is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The Company, through its subsidiary CanniMed Ltd, offers medical cannabis oils, dried medical cannabis, vaporizers, vaporizer parts and accessories. Its CanniMed Oils are made using only dried cannabis flowers. Its vaporizers include Arizer Air vaporizer and Volcano Medic vaporizer. Its vaporizer parts and accessories include ARIZER AIR All Glass Tube (no mouthpiece), ARIZER AIR Charger/Power Adapter, ARIZER AIR Dual Battery Charger, ARIZER AIR Glass Tube with black mouthpiece, ARIZER AIR Replacement Battery, Volcano Medic Air Filter Cap and Volcano Medic Air Filter Set.